— Know what they know.
Not Investment Advice
Also trades as: 2784.T (JPX) · $vol 7M · ALFRY (OTC) · $vol 0M

ARHCF OTC

Alfresa Holdings Corporation
1W: +nan% 1M: -100.0% 3M: -100.0% YTD: -100.0% 1Y: -100.0% 3Y: -100.0% 5Y: -100.0%
$14.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Distribution · Tech Score Neutral · Power 46 · $2.5B mcap · 141M float · 0.0001% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.5B
52W Range11.87-14.59
Volume2,700
Avg Volume142
Beta0.08
Dividend$0.44
Analyst Ratings
No analyst coverage
Company Info
CEORyuji Arakawa
Employees12,525
SectorHealthcare
IndustryMedical - Distribution
IPO Date2007-07-24
Ote Center Building
Tokyo, SA 100-0004
JP
81 3 5219 5100
About Alfresa Holdings Corporation

Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells over-the-counter drugs, health food, and supplements. The Manufacturing segment manufactures and markets pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. The Medical-related segment offers medical services through its dispensing pharmacies. The company was founded on September 29, 2003 and is headquartered in Tokyo, Japan.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms